Jim Simons Enanta Pharmaceuticals Inc Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 510,900 shares of ENTA stock, worth $5.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
510,900
Previous 526,100
2.89%
Holding current value
$5.8 Million
Previous $9.19 Million
27.87%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding ENTA
# of Institutions
100Shares Held
21MCall Options Held
10.4KPut Options Held
2.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$23.8 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$21 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.46MShares$16.5 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.25MShares$14.2 Million7.45% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $235M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...